Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role
APOE
carrier status
Authors
Keywords
-
Journal
Alzheimers & Dementia
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-08-17
DOI
10.1002/alz.12161
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Alzheimer Research, Glucose Metabolism Moves to Center Stage
- (2020) Bridget M. Kuehn JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer’s disease: Pooled analysis from 5 cohorts
- (2019) Galit Weinstein et al. PLoS One
- Metformin Therapy Aggravates Neurodegenerative Processes in ApoE– /– Mice
- (2019) Angela Kuhla et al. JOURNAL OF ALZHEIMERS DISEASE
- Metformin treatment improves the spatial memory of the aged mice in an APOE genotype–dependent manner
- (2019) Jing Zhang et al. FASEB JOURNAL
- The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice
- (2019) Yuriko Nakaoku et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of vildagliptin, a DPP-4 inhibitor, in elderly diabetic patients with mild cognitive impairment
- (2019) Antonio Maria Borzì et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case–control study
- (2019) Ida Kim Wium-Andersen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging
- (2018) Alexandra M.V. Wennberg et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
- (2018) Jared M. Campbell et al. JOURNAL OF ALZHEIMERS DISEASE
- ggplot2 - Elegant Graphics for Data Analysis (2nd Edition)
- (2017) Virgilio Gómez-Rubio Journal of Statistical Software
- Metformin – a Future Therapy for Neurodegenerative Diseases
- (2017) Magdalena Markowicz-Piasecka et al. PHARMACEUTICAL RESEARCH
- Biological and biophysics aspects of metformin-induced effects: cortex mitochondrial dysfunction and promotion of toxic amyloid pre-fibrillar aggregates
- (2016) Pasquale Picone et al. Aging-US
- Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice
- (2016) Wilma Helena Oliveira et al. BRAIN RESEARCH
- Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation
- (2016) Sung Min Son et al. JOURNAL OF ALZHEIMERS DISEASE
- Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial
- (2016) José A. Luchsinger et al. JOURNAL OF ALZHEIMERS DISEASE
- Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer’s Disease
- (2016) Jayasankar Kosaraju et al. MOLECULAR NEUROBIOLOGY
- Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-κB activation: Use of insulin to attenuate metformin's effect
- (2015) Pasquale Picone et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Fitting Linear Mixed-Effects Models Usinglme4
- (2015) Douglas Bates et al. Journal of Statistical Software
- ipw: AnRPackage for Inverse Probability Weighting
- (2015) Willem M. van der Wal et al. Journal of Statistical Software
- The Effects of Dipeptidyl Peptidase-4 Inhibition on Microvascular Diabetes Complications
- (2014) Angelo Avogaro et al. DIABETES CARE
- Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
- (2014) Erin E. Mulvihill et al. ENDOCRINE REVIEWS
- Dipeptidyl Peptidase-4 Inhibitors Have Protective Effect on Cognitive Impairment in Aged Diabetic Patients With Mild Cognitive Impairment
- (2014) M. R. Rizzo et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Effect of thiazolidinediones and insulin on cognitive outcomes in ACCORD-MIND
- (2013) Elizabeth R. Seaquist et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease
- (2013) Jayasankar Kosaraju et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease
- (2013) Jayasankar Kosaraju et al. NEUROPHARMACOLOGY
- Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice
- (2012) Jiejie Li et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD and wild-type mice
- (2012) F Masciopinto et al. Cell Death & Disease
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies
- (2011) C. Harrington et al. Current Alzheimer Research
- Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2010) Michael Gold et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Rosiglitazone and Cognitive Stability in Older Individuals With Type 2 Diabetes and Mild Cognitive Impairment
- (2010) A. M. Abbatecola et al. DIABETES CARE
- Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders
- (2009) Louis A. Profenno et al. BIOLOGICAL PSYCHIATRY
- Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer’s prone mice
- (2009) Michele D’Amico et al. EXPERIMENTAL GERONTOLOGY
- Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes
- (2008) Judith Miklossy et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation